JDL(SH:688057) Sou Hu Cai Jing·2025-12-21 09:44Core Viewpoint - Jindalai (688057.SH) plans to invest 30 million yuan in Beijing Zhongke Hongtai Medical Technology Co., Ltd., acquiring a 10% stake, aiming to optimize its industrial structure and seek new growth opportunities [1] Group 1: Investment Details - The investment will be made using the company's own funds amounting to 30 million yuan [1] - After the investment, Jindalai will hold a 10% equity stake in Zhongke Hongtai [1] Group 2: Company Background - Zhongke Hongtai specializes in the research, production, and sales of medical robot technology and systems [1] - The company was incubated by the Institute of Automation, Chinese Academy of Sciences, and is led by a team of experts including Professor Hou Zengguang [1] - Since 2008, the founding team has undertaken over 10 major projects, including the first domestic 863 program for vascular interventional surgical robots [1] Group 3: Financial Status and Purpose of Investment - Zhongke Hongtai is currently not profitable [1] - The investment aims to enhance the company's risk resistance and cultivate new profit growth points [1] - Funds from the investment will be allocated for technology research and development, market promotion, and daily operations [1]